Chiropractors in Wentzville, MO Accepting Medicare
67 Chiropractors found. Showing 61 - 67
 Runge Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 1000 Corporate Pkwy, Suite102, Wentzville, MO 63385 Phone: 636-327-4446 Fax: 636-327-0446 |
Advanced Family Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1023 Main Plaza Dr, Wentzville, MO 63385 Phone: 636-327-3333 Fax: 636-639-8922 |
Baird Spine And Sport Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 905 Main Plaza Dr, Wentzville, MO 63385 Phone: 636-856-1260 Fax: 636-856-1245 |
 Dr. Steven Jerome Meacham, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1023 Main Plaza Dr, Wentzville, MO 63385 Phone: 636-327-3333 Fax: 636-639-8922 |
Dr. John Richard Spraul, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 512 W Pearce Blvd, Wentzville, MO 63385 Phone: 636-327-8080 Fax: 636-327-8080 |
Wentzville Wellness Center D.c., P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 1816 W Pearce Blvd, Wentzville, MO 63385 Phone: 636-327-8515 Fax: 636-327-8316 |
Twc Wezville Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1229 Wentzville Pkwy Ste 201, Wentzville, MO 63385 Phone: 636-327-8811 |
News Archive
U.K., U.S., Australia, Gates Foundation promise funds to GAVI Alliance at pledging conference
At a pledging conference for the GAVI Alliance in London on Monday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation and Microsoft founder, announced his foundation will provide an additional $1 billion in funding for the organization over the next five years, while Australian Foreign Minister Kevin Rudd said his country will provide $210 million over the next three years, Reuters reports.
Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome
RegeneRx Biopharmaceuticals, Inc. today announced positive data from its 72-patient, Phase 2 clinical trial with RGN-259, a sterile, preservative-free eye drop, to evaluate its safety and efficacy for the treatment of signs and symptoms of dry eye syndrome over a treatment period of 30 days using the Controlled Adverse Environment (CAE) model.
George Washington University releases 'Obesity Drug Outcome Measures'
The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.
Misonix signs new distribution agreement with Varlix Mexico
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Varlix Mexico, S.A. de C.V., based in Mexico City, Mexico, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter. The agreement provides Varlix with the rights to sell exclusively in Mexico and includes minimum purchase requirements.
› Verified 4 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Optometrists
Podiatrists